Early MRI-Derived Volumetric Thresholds Predict Response and Guide Personalization in HER2-Positive Breast Cancer: A Retrospective Study

Hao Yao, Xuyang Qian, Ran Zheng, Xingye Sheng, Jingjing Ding, Mingyu Wang, Xiaoming Zha, Shouju Wang, Jue Wang, Mohamad Adam Bujang · 2025

Read Early MRI-Derived Volumetric Thresholds Predict Response and Guide Personalization in HER2-Positive Breast Cancer: A Retrospective Study by Hao Yao, Xuyang Qian, Ran Zheng, Xingye Sheng, Jingjing Ding, Mingyu Wang, Xiaoming Zha, Shouju Wang, Jue Wang, Mohamad Adam Bujang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12730305.txt.

Description

A peer-reviewed research article from Europe PMC (2025). Background: Neoadjuvant systemic therapy (NST), whose primary purposes include response assessment and treatment individualization, is a key strategy in the treatment of HER2-positive breast cancer. This study investigated the predictive value of the magnetic resonance imaging (MRI)-derived tumor volume reduction rate (δV1) for the early identification of pathological complete response (pCR) during NST and established clinically applicable δV1 thresholds for patient stratification. Methods: HER2-positive breast cancer patients who received THP (taxane, trastuzumab, pertuzumab) followed by epirubicin/cyclophosphamide (EC) were enrolled.

Catalog record

CREATORHao Yao, Xuyang Qian, Ran Zheng, Xingye Sheng, Jingjing Ding, Mingyu Wang, Xiaoming Zha, Shouju Wang, Jue Wang, Mohamad Adam Bujang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12730305

Browse the full library · About the Tower of Babel